Grand Pharma Plans Bye-Law Overhaul to Meet HKEX Paperless, Treasury Share Requirements

Bulletin Express04-29

Grand Pharmaceutical Group Limited (Grand Pharma) has announced a proposal to replace its existing bye-laws with a new set designed to align with forthcoming Hong Kong Stock Exchange (HKEX) regulatory changes.

The board intends to update the governance framework to: • Comply with HKEX’s expanded paperless listing regime. • Enable electronic dissemination of corporate communications to shareholders. • Incorporate the exchange’s new treasury shares provisions. • Facilitate the future implementation of an uncertificated securities market. • Introduce related housekeeping changes for consistency.

The adoption of the revised bye-laws will be put to shareholders as a special resolution at the company’s annual general meeting scheduled for 5 June 2026. A detailed circular outlining the proposed amendments and the AGM notice will be distributed to shareholders in due course.

As of the announcement date (30 April 2026), Grand Pharma’s board consists of four executive directors—Dr. Tang Weikun (Chairman), Mr. Zhou Chao, Mr. Yang Guang and Ms. Lam Chit Yee Jessica—and four independent non-executive directors: Ms. So Tosi Wan, Winnie, Dr. Xing Li Na, Dr. Pei Geng and Mr. Hu Yebi.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1173381469?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-29 20:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1173381469","market":"hk","top_or_hot":-1,"title":"Grand Pharma Plans Bye-Law Overhaul to Meet HKEX Paperless, Treasury Share Requirements","media":"Bulletin Express","content":"<p>Grand Pharmaceutical Group Limited (Grand Pharma) has announced a proposal to replace its existing bye-laws with a new set designed to align with forthcoming Hong Kong Stock Exchange (HKEX) regulatory changes.</p>\n<p>The board intends to update the governance framework to:\n• Comply with HKEX’s expanded paperless listing regime.  \n• Enable electronic dissemination of corporate communications to shareholders.  \n• Incorporate the exchange’s new treasury shares provisions.  \n• Facilitate the future implementation of an uncertificated securities market.  \n• Introduce related housekeeping changes for consistency.</p>\n<p>The adoption of the revised bye-laws will be put to shareholders as a special resolution at the company’s annual general meeting scheduled for 5 June 2026. A detailed circular outlining the proposed amendments and the AGM notice will be distributed to shareholders in due course.</p>\n<p>As of the announcement date (30 April 2026), Grand Pharma’s board consists of four executive directors—Dr. Tang Weikun (Chairman), Mr. Zhou Chao, Mr. Yang Guang and Ms. Lam Chit Yee Jessica—and four independent non-executive directors: Ms. So Tosi Wan, Winnie, Dr. Xing Li Na, Dr. Pei Geng and Mr. Hu Yebi.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Grand Pharma Plans Bye-Law Overhaul to Meet HKEX Paperless, Treasury Share Requirements</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGrand Pharma Plans Bye-Law Overhaul to Meet HKEX Paperless, Treasury Share Requirements\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-29 20:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Grand Pharmaceutical Group Limited (Grand Pharma) has announced a proposal to replace its existing bye-laws with a new set designed to align with forthcoming Hong Kong Stock Exchange (HKEX) regulatory changes.</p>\n<p>The board intends to update the governance framework to:\n• Comply with HKEX’s expanded paperless listing regime.  \n• Enable electronic dissemination of corporate communications to shareholders.  \n• Incorporate the exchange’s new treasury shares provisions.  \n• Facilitate the future implementation of an uncertificated securities market.  \n• Introduce related housekeeping changes for consistency.</p>\n<p>The adoption of the revised bye-laws will be put to shareholders as a special resolution at the company’s annual general meeting scheduled for 5 June 2026. A detailed circular outlining the proposed amendments and the AGM notice will be distributed to shareholders in due course.</p>\n<p>As of the announcement date (30 April 2026), Grand Pharma’s board consists of four executive directors—Dr. Tang Weikun (Chairman), Mr. Zhou Chao, Mr. Yang Guang and Ms. Lam Chit Yee Jessica—and four independent non-executive directors: Ms. So Tosi Wan, Winnie, Dr. Xing Li Na, Dr. Pei Geng and Mr. Hu Yebi.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00512","symbol_name":"远大医药","start_time":0,"source_url":"","article_id":"1173381469","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1173381469","pubTimestamp":1777465509,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Grand Pharmaceutical Group Limited (Grand Pharma) has announced a proposal to replace its existing bye-laws with a new set designed to align with forthcoming Hong Kong Stock Exchange (HKEX)...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00512":"远大医药"},"translate_title":"远大医药计划修改公司细则以满足港交所无纸化库存股要求","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00512":1},"content_text":"Grand Pharmaceutical Group Limited (Grand Pharma) has announced a proposal to replace its existing bye-laws with a new set designed to align with forthcoming Hong Kong Stock Exchange (HKEX) regulatory changes.\nThe board intends to update the governance framework to:\n• Comply with HKEX’s expanded paperless listing regime.  \n• Enable electronic dissemination of corporate communications to shareholders.  \n• Incorporate the exchange’s new treasury shares provisions.  \n• Facilitate the future implementation of an uncertificated securities market.  \n• Introduce related housekeeping changes for consistency.\nThe adoption of the revised bye-laws will be put to shareholders as a special resolution at the company’s annual general meeting scheduled for 5 June 2026. A detailed circular outlining the proposed amendments and the AGM notice will be distributed to shareholders in due course.\nAs of the announcement date (30 April 2026), Grand Pharma’s board consists of four executive directors—Dr. Tang Weikun (Chairman), Mr. Zhou Chao, Mr. Yang Guang and Ms. Lam Chit Yee Jessica—and four independent non-executive directors: Ms. So Tosi Wan, Winnie, Dr. Xing Li Na, Dr. Pei Geng and Mr. Hu Yebi.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1173381469","isCrawlerRequest":true}